Skip to main content
Company Offering
SEC Accession #

0001669191-22-000335

Platform Raised on
Filing Date
Deadline Date

Investment Security Details

Submission
Offering Statement
Nature of Ammendment
the issuer is extending the offering deadline.
Price of Security
$2.55
# Securities
3,922
Capital Type

Common Stock

Max Offering
$1,069,997.85
Price Detail
The price of the Securities was determined solely by Management and bears no relation to traditional measures of valuation such as book value or price-to-earnings rat... [Truncated: see complete discussion in attachment offeringstatement.pdf, question 21.]

Investing Platform Detail

Platform Comp
Up to 4.9% of amount raised for a successful offering and a listing fee of up to $5,000
Financial Interest
None.

Offering Company Details

Executive Signatory
Pamela Contag
Title
Principal Executive Officer
Website
https://www.bioeclipse.com
Employee Count at Offering
5
SEC CIK
1780708
FILE NUMBER
020-29552

Comments